SHIELDED LIVING THERAPEUTICS Trademark

Trademark Overview


On Friday, November 16, 2018, a trademark application was filed for SHIELDED LIVING THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SHIELDED LIVING THERAPEUTICS trademark a serial number of 88197571. The federal status of this trademark filing is REGISTERED as of Tuesday, October 6, 2020. This trademark is owned by Sigilon Therapeutics, Inc.. The SHIELDED LIVING THERAPEUTICS trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells

Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use
shielded living therapeutics

General Information


Serial Number88197571
Word MarkSHIELDED LIVING THERAPEUTICS
Filing DateFriday, November 16, 2018
Status700 - REGISTERED
Status DateTuesday, October 6, 2020
Registration Number6170098
Registration DateTuesday, October 6, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements


Goods and ServicesChemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells
Goods and ServicesChemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, December 4, 2018
Primary Code001
First Use Anywhere DateFriday, June 5, 2020
First Use In Commerce DateFriday, June 5, 2020

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 4, 2018
Primary Code005
First Use Anywhere DateTuesday, July 28, 2020
First Use In Commerce DateTuesday, July 28, 2020

Trademark Owner History


Party NameSigilon Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameSigilon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameSigilon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, March 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 18, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 18, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 6, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, September 1, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 31, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 31, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, August 17, 2020USE AMENDMENT FILED
Monday, August 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 17, 2020TEAS STATEMENT OF USE RECEIVED
Friday, April 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2020SOU EXTENSION 1 GRANTED
Wednesday, April 8, 2020SOU EXTENSION 1 FILED
Wednesday, April 8, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 5, 2019ASSIGNED TO LIE
Thursday, July 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 24, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 22, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, February 22, 2019PRIORITY ACTION E-MAILED
Friday, February 22, 2019PRIORITY ACTION WRITTEN
Wednesday, February 20, 2019ASSIGNED TO EXAMINER
Tuesday, December 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 20, 2018NEW APPLICATION ENTERED